InvestorsHub Logo
Followers 4
Posts 2010
Boards Moderated 0
Alias Born 09/19/2008

Re: None

Thursday, 02/12/2015 1:22:43 PM

Thursday, February 12, 2015 1:22:43 PM

Post# of 12137
Here's an excerpt from the most recent CYRX conference call.

"For example in the CAR-T cell area we’re already working with Novartis on clinical trials and we’re in early stages with newer companies such as GeNO Therapeutics, Silicon Pharmaceuticals, Argus Therapeutics, BlueBird Bio and Kite Pharma."

Logistics is so important to the new wave of personalized medicine, that one of the names mentioned in the JS conference call, Argos, had this to present, just recently.

"Dr. Miesowicz is scheduled to present a case study during a focus session titled, "Logistics 1: Placing logistics at the heart of the cell and gene therapy business model,"

Think about that!!!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYRX News